Creo Medical Group (LON:CREO) Share Price Passes Below 50-Day Moving Average – What’s Next?

Posted by Francis Steltz on Aug 1st, 2026

Creo Medical Group PLC (LON:CREO – Get Free Report)’s stock price crossed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 13.90 and traded as low as GBX 13.03. Creo Medical Group shares last traded at GBX 13.44, with a volume of 166,113 shares changing hands.

Analysts Set New Price Targets

Separately, Shore Capital Group reaffirmed a “house stock” rating and issued a GBX 40 price target on shares of Creo Medical Group in a research report on Thursday, July 23rd.

Check Out Our Latest Report on Creo Medical Group

Creo Medical Group Stock Down 1.4%

The company’s fifty day simple moving average is GBX 13.87 and its 200-day simple moving average is GBX 13.39. The firm has a market capitalization of £63.45 million, a PE ratio of 13.06 and a beta of 1.62. The company has a debt-to-equity ratio of 8.20, a current ratio of 3.22 and a quick ratio of 2.19.

Creo Medical Group (LON:CREO – Get Free Report) last issued its quarterly earnings data on Friday, May 22nd. The company reported GBX (0.04) EPS for the quarter. The business had revenue of GBX 600 million for the quarter. Creo Medical Group had a net margin of 88.33% and a return on equity of 9.56%. On average, analysts forecast that Creo Medical Group PLC will post -10.0800005 EPS for the current year.

Insider Activity

In other Creo Medical Group news, insider Craig Jonathan Gulliford purchased 6,250 shares of the company’s stock in a transaction dated Wednesday, July 1st. The shares were acquired at an average price of GBX 14 per share, for a total transaction of £875. Also, insider Richard John Rees acquired 6,250 shares of the business’s stock in a transaction dated Wednesday, July 1st. The shares were bought at an average price of GBX 14 per share, for a total transaction of £875. 6.92% of the stock is currently owned by company insiders.

Creo Medical Group Company Profile

(Get Free Report)

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.

The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive. The Group has developed the CROMA powered by Kamaptive full-spectrum adaptive technology to optimise surgical capability and patient outcomes.